0001209191-15-067186.txt : 20150820
0001209191-15-067186.hdr.sgml : 20150820
20150820181352
ACCESSION NUMBER: 0001209191-15-067186
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150820
FILED AS OF DATE: 20150820
DATE AS OF CHANGE: 20150820
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001124105
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562020050
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 260 LITTLEFIELD AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6507450655
MAIL ADDRESS:
STREET 1: 260 LITTLEFIELD AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: TARGACEPT INC
DATE OF NAME CHANGE: 20000919
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Payne Fletcher
CENTRAL INDEX KEY: 0001650476
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51173
FILM NUMBER: 151067192
MAIL ADDRESS:
STREET 1: 260 LITTLEFIELD AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-08-20
0
0001124105
CATALYST BIOSCIENCES, INC.
CBIO
0001650476
Payne Fletcher
260 LITTLEFIELD AVNUE
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Financial Officer
Common Stock
2015-08-20
4
J
0
15032
A
15032
I
By Charles and Nancy Payne 2000 Trust
Stock Option (Right to Buy)
7.60
2015-08-20
4
J
0
7320
A
2025-01-22
Common Stock
7320
7320
D
Stock Option (Right to Buy)
7.60
2015-08-20
4
J
0
2440
A
2025-01-22
Common Stock
2440
2440
D
Stock Option (Right to Buy)
6.03
2015-08-20
4
J
0
14325
A
2025-05-08
Common Stock
14325
14325
D
Represents shares of the Issuer issued pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 5, 2015 as amended on May 6 and May 13, 2015, by and among the Issuer, Talos Merger Sub, Inc. and a Delaware corporation then known as Catalyst Biosciences, Inc. ("Old Catalyst"). Pursuant to the terms of the Merger Agreement, each share of common stock of Old Catalyst was converted into 0.0382 shares of the Issuer's common stock.
On January 22, 2015, Reporting Person was granted an option to purchase 191,635 shares of the common stock of Old Catalyst under Old Catalyst's Out of Plan Options at an exercise price of $0.29 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 7,320 shares of the Catalyst's common stock at a per share exercise price of $7.60. The option is fully vested and exercisable.
On January 22, 2015, Reporting Person was granted an option to purchase 63,878 shares of the common stock of Old Catalyst under Old Catalyst's Out of Plan Options at an exercise price of $0.29 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 2,440 shares of the Catalyst's common stock at a per share exercise price of $7.60. The option is fully vested and exercisable.
On May 8, 2015, Reporting Person was granted an option to purchase 375,000 shares of the common stock of Old Catalyst under Old Catalyst's Out of Plan Options at an exercise price of $0.23 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 14,325 shares of the Catalyst's common stock at a per share exercise price of $6.03. Subject generally to the Reporting Person's continued employment, the option vests at the rate of 1/48th of the number of shares on the 1st of each month with the first month vesting on May 1, 2015.
/s/ Nassim Usman Attorney-in-Fact for Fletcher Payne
2015-08-20